Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2025-12-25 @ 2:58 AM
NCT ID:
NCT05886933
Eligibility Criteria:
Inclusion Criteria:
1. Adult aged 19 years to 75 years (on registration date)
2. Patient scheduled to administer Fexuclue tablet based on the medical judgment of investigator.
3. Patient who has not taken a treatment for gastroesophageal reflux disease within two weeks from baseline visit.
4. Patient who agreed to participate in this observation study and signed Informed Consent Form
Exclusion Criteria:
1. A person who falls under the prohibition of administration according to the permission for Fexuclue Tablet
* Patients with hypersensitivity to the components of Fexuclue tablet or Fexuclue tablet and a history thereof
* Patients undergoing Atazanavir, Nelfinavir or Lilpivirin-containing preparations
* Pregnant and lactating women
* Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabortion
2. A person who has taken a treatment for gastroesophageal reflux disease within two weeks from baseline visit.
3. In addition to the above, a person who has determined that the researcher (the doctor in charge) is not suitable for participation in this observation study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
75 Years
Study:
NCT05886933
Study Brief:
Protocol Section:
NCT05886933